April 15, 2008 -- Two development stage Scottish pharmaceutical companies have signed deals with AsiaPharm (SI: ASPH). Under the agreements, AsiaPharm will seek to obtain SFDA approval for drugs from GlycoMar of Oban, Scotland, and from Scottish Biomedical of Glasgow. If AsiaPharm is successful in obtaining SFDA approval, AsiaPharm can license the marketing rights for the drugs. Financial details of the agreements were not disclosed. More details...
